sle

Documents about sle

• Acthar SLE (Systemic Lupus Erythematosus)#839253ClinicalTrials.gov
• UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients#838628ClinicalTrials.gov
• MB-CART19.1 in Refractory SLE#839427ClinicalTrials.gov
• A Study of CD19 Redirected Autologous T Cells for CD19 Positive Systemic Lupus Erythematosus (SLE)#842983ClinicalTrials.gov
• An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE).#886294ClinicalTrials.gov
• Phase 1b/2a in SLE With Budoputug#894260ClinicalTrials.gov
• Efficacy of Vitamin C Supplementation on Malondialdehid Levels and Disease Activity in SLE Patients#905017ClinicalTrials.gov
• Anti-CD20 Antibodies for Treatment of SLE-PAH#651173ClinicalTrials.gov
• A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE)#872224ClinicalTrials.gov
• Phase 1 Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)#804106ClinicalTrials.gov
• Does Balnotherapy Influence the Qualitiy of Life in SLE#901944ClinicalTrials.gov
• European LUpuS Inception-Cohort Developing initiATivE#904158ClinicalTrials.gov
• A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)#876103ClinicalTrials.gov
• EG-501 for Cognitive Impairment in Neuropsychiatric SLE (NPSLE): Efficacy and Safety Study#839041ClinicalTrials.gov
• Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)#847414ClinicalTrials.gov
• Phase 2 Study of Belimumab Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus (SLE)#833848ClinicalTrials.gov
• The Effect of Vitamin D Supplementation on Disease Activity Markers in Systemic Lupus Erythematosus (SLE)#839404ClinicalTrials.gov
• Myocardial Inflammation in Systemic Lupus Erythematosus#846153ClinicalTrials.gov
• Anifrolumab Pregnancy Study#895974ClinicalTrials.gov
• Evaluation of Type I IFN Level and Disease Activity in SLE Patients#880366ClinicalTrials.gov
• Study During Pregnancy of Expression of miRNAs in RA or SLE#915413ClinicalTrials.gov
• Maxillary Reconstruction Timing in Severe Systemic Lupus Erythematous (SLE) Patient with Bone Destruction due to Invasive Aspergillosis: Case Report#930427Acta Interna: The Journal of Internal Medicine
• Leflunomide in Systemic Lupus Erythematosus#826007ClinicalTrials.gov
• A multiethnic, multicenter cohort of patients with Systemic Lupus Erythematosus (SLE) as a model for the study of ethnic disparities in SLE#277436Repositorio Universidad Peruana Cayetano Heredia
• Argentinian Prospective Registry of Patients With Lupus#904844ClinicalTrials.gov
• COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders#217105ClinicalTrials.gov
• Anti-CD19 CAR-T Cell Therapy for Patients With Refractory Systemic Lupus Erythematosus#813961ClinicalTrials.gov
• Chemokine (CXCL13) as Anew Marker in Diagnosis of SLE#861625ClinicalTrials.gov
• SLE Vasculitis In Egyptian Patients#904185ClinicalTrials.gov
• A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms.#805121ClinicalTrials.gov
• Safety and Immunogenicity of a Zoster Vaccine in SLE#158033ClinicalTrials.gov
• Steroid-induced Diabetes Mellitus in Systemic Lupus Erythematosus (SLE) Patients#181707ClinicalTrials.gov
• Evaluation Of Serum MIF Level in SLE Patients#858465ClinicalTrials.gov
• An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus Erythematosus#906398ClinicalTrials.gov
• Accelerated immunosenescence in SLE: current evidence and clinical translation.#334827NCBI PubMed Central
• BElimumab corticoSteroids Sparing Treatment in Systemic Lupus Erythematosus#905164ClinicalTrials.gov
• Clinical Study of Cizutamig in Systemic Lupus Erythematosus#993132ClinicalTrials.gov
• BI 705564 in Patients With Systemic Lupus Erythematosus (SLE)#993506ClinicalTrials.gov
• A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease#845891ClinicalTrials.gov
• Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)#887775ClinicalTrials.gov
• Large deviations of SLE(0+) variants in the capacity parameterization#144260arXiv (OAI)
• Telitacicept Followed With Rituximab Therapy on APS Secondary to SLE#158096ClinicalTrials.gov
• Transcutaneous Vagus Nerve Stimulation in SLE#830665ClinicalTrials.gov
• Association Between Neuropathy and Some Autoantibodies in Systemic Lupus Erythematosus (SLE) Patients#868624ClinicalTrials.gov
• Scrutinizing the Heterogeneity of SLE: Defining Phenotypes#897345ClinicalTrials.gov
• Anifrolumab Asian PhIII Efficacy Study for Systemic Lupus Erythematosus (SLE)#917038ClinicalTrials.gov
• Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE)#884244ClinicalTrials.gov
• A Study to Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamics of Cenerimod in Adult Chinese Participants With Moderate-to-severe Systemic Lupus Erythematosus (SLE)#850257ClinicalTrials.gov
• Proline-rich acidic protein 1 in Life and Death#645083ScholarBank@NUS
• Sequential Belimumab and T-cell Based Therapy in SLE#861905ClinicalTrials.gov